Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Trodelvy gets EU nod for first-line triple-neg breast cancer
14+ hour, 29+ min ago (215+ words) This follows on a similar FDA approval in June and makes the Trodelvy plus Keytruda regimen the first ADC-immunotherapy combination approved in this indication in both the US and Europe. Trodelvy was also already approved in the EU as a…...
Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug HM17321
19+ hour, 11+ min ago (354+ words) Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity drug HM17321, as the US-based drugmaker looks to explore treatments that can preserve muscle alongside weight loss. Genentech will pay Hanmi $190 million upfront…...
Japan first approval for GSK???s bepirovirsen for CHB
22+ hour, 50+ min ago (371+ words) GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Hibsago (bepirovirsen), an antisense oligonucleotide (ASO), as a functional cure in chronic hepatitis B (CHB) virus infection in adult patients who have received at least six…...
In schizophrenia care, even the support system needs support
23+ hour, 23+ min ago (563+ words) The National Institute of Mental Health (NIMH) describes schizophrenia as “a serious mental illness that affects how a person thinks, feels and behaves.” At times, the nature of schizophrenia may even disrupt a person’s sense of reality. Those moments can…...
UK MHRA authorises orforglipron private prescription
1+ day, 9+ hour ago (427+ words) Eli Lilly has announced that orforglipron (Foundayo), its oral glucagon-like peptide-1 (GLP-1) receptor agonist, is now available to be prescribed for eligible adults via private prescription following its approval by the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday…...
AI, genomics expert leaves Pathos AI, will advise Pfizer
3+ day, 19+ hour ago (224+ words) Eric Schadt, a serial entrepreneur and expert in computational biology, is leaving his post as chief scientist at Pathos AI to start a new, stealthy venture - and signing on as Pfizer's first AI Scholar in the process. "I’m excited to…...
J&J scores EU approval for Tecvayli combo in second line
3+ day, 15+ hour ago (185+ words) Johnson & Johnson has secured another approval for its multiple myeloma drug Tecvayli (teclistamab), with the European Commission granting approval for the drug in combination with Darzalex (daratumumab) for relapsed/refractory multiple myeloma. The drug previously had a conditional approval in…...
When metrics measure more than they improve
3+ day, 23+ hour ago (766+ words) Yet, despite all this measurement, site performance often doesn't improve. Why? Because measuring performance isn't the same as improving it. The question we should be asking is not, "Are we measuring site performance?" but, "Are the metrics we collect providing…...
Bioptimus, Cancer Research Horizons partner on AI-powered precision medicine
4+ day, 3+ min ago (386+ words) Paris, France-based Bioptimus, a global AI biotech company, has announced a partnership with Cancer Research Horizons, the innovation engine of Cancer Research UK, to advance AI-powered precision medicine. The agreement allows Bioptimus to access S:CORT (Stratification in COloRectal cancer Trial),…...
Claude Science outperforms experts in protein binder task
4+ day, 15+ hour ago (264+ words) Some of Claude's protein designs Anthropic's Claude Science performed impressively in a protein design exercise, designing binders against 14 out of 15 targets and improving, in many cases, on the results of design competitions tackling those same targets. Anthropic published a detailed…...